SearchDictionaryMobileLogin

Analyses of dynamic beat-to-beat QT-TQ interval (ECG restitution) changes in humans under normal sinus rhythm and prior to an event of torsades de pointes during QT prolongation caused by sotalol.

AbstractBACKGROUND: Restitution through intracardiac pacing has been used to assess arrhythmia vulnerability. We examined whether analyses of sequential beat-to-beat QT and TQ interval measures can be used to quantify ECG restitution changes under normal sinus rhythm. METHODS: The QT, R-R and TQ intervals were examined 22.5 hour Holter monitoring before and after oral sotalol in normal male and female volunteers. Additionally, comparisons were made to those observed in the time-matched dataset prior to torsades de pointes in a heart diseased patient that received a single dose of sotalol. RESULTS: Sotalol increased QT, R-R and TQ intervals 71, 101, and 125 ms after 160 mg (n = 38) and 194, 235, and 135 ms after 320 mg (n = 19) during maximum plasma concentrations, respectively. The percentage of beats with a QT/TQ ratio >1 was reduced 25% over the entire 22.5 hours after sotalol and the lower TQ interval boundary (5th quantile) was increased 22-30%. In contrast, 99% of the beats prior to torsades de pointes had a QT/TQ ratio > 1 and the median TQ interval was below the lower 98% confidence bounds of normals before and after sotalol. CONCLUSIONS: ECG restitution changes are quantifiable under varying states (nocturnally, beta-adrenergic blockade, QT prolongation) in healthy subjects.
AuthorsAnthony A Fossa, Todd Wisialowski, Kimberly Crimin, Eric Wolfgang, Jean-Philippe Couderc, Martin Hinterseer, Stefan Kaab, Wojciech Zareba, Fabio Badilini, Nenad Sarapa (Affiliation: Pfizer Global Research and Development, Groton, Connecticut 06340, USA. anthony.a.fossa at pfizer.com)
JournalAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc (Ann Noninvasive Electrocardiol) Vol. 12 Issue 4 Pg. 338-48 (Oct 2007) ISSN: 1082-720X United States
PMID17970959 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Arrhythmia Agents
  • Sotalol
Topics
  • Adolescent
  • Adult
  • Anti-Arrhythmia Agents (pharmacology)
  • Electrocardiography, Ambulatory
  • Female
  • Humans
  • Long QT Syndrome (chemically induced, physiopathology)
  • Male
  • Middle Aged
  • Sotalol (pharmacology)
  • Statistics, Nonparametric
  • Torsades de Pointes (chemically induced, physiopathology)